The Discounted Cash Flow (DCF) valuation of Regeneron Pharmaceuticals Inc (REGN) is 796.02 USD. With the latest stock price at 665.46 USD, the upside of Regeneron Pharmaceuticals Inc based on DCF is 19.6%.
Range | Selected | |
WACC / Discount Rate | 8.4% - 10.5% | 9.4% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | 632.42 - 1,157.59 | 796.02 |
Upside | -5.0% - 74.0% | 19.6% |